Phase III randomized trial of sunitinib malate (SU11248) versus interferon-alfa (IFN-Α) as first-line systemic therapy for patients with metastatic renal cell carcinoma (mRCC) Meeting Abstract
| Authors: | Motzer, R. J.; Hutson, T. E.; Tomczak, P.; Michaelson, M. D.; Bukowski, R. M.; Rixe, O.; Oudard, S.; Kim, S. T.; Baum, C. M.; Figlin, R. A. |
| Abstract Title: | Phase III randomized trial of sunitinib malate (SU11248) versus interferon-alfa (IFN-Α) as first-line systemic therapy for patients with metastatic renal cell carcinoma (mRCC) |
| Meeting Title: | 31st ESMO Congress |
| Journal Title: | Annals of Oncology |
| Volume: | 17 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2006 Sep 29-Oct 3 |
| Meeting Location: | Istanbul, Turkey |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2006-09-01 |
| Start Page: | ix53 |
| End Page: | ix54 |
| Language: | English |
| ACCESSION: | WOS:000248078900092 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdl203 |
| PUBMED: | 17018761 |
| Notes: | Meeting Abstract: 81IN - 31st Congress of the European-Society-for-Medical-Oncology - SEP 29-OCT 03, 2006 - Istanbul, TURKEY - "Source: Wos" |
